pentobarbital decreases results of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers may well minimize sufentanil concentrations and efficacy, possibly precipitating withdrawal syndrome in individuals who've formulated Actual physical dependence to su